<?xml version="1.0" encoding="UTF-8"?>
<ref id="B169-ijms-21-05559">
 <label>169.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Momekov</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Momekova</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: Antiviral levels are not likely attainable with known dosing regimens</article-title>
  <source>Biotechnol. Biotechnol. Equip.</source>
  <year>2020</year>
  <volume>34</volume>
  <fpage>469</fpage>
  <lpage>474</lpage>
  <pub-id pub-id-type="doi">10.1080/13102818.2020.1775118</pub-id>
 </element-citation>
</ref>
